Navigation Links
FDA Mandates Black Box Warning for Some Antibiotics
Date:7/8/2008

s. Tendons are the areas that connect muscles to joints.

Prior to requesting the black box warning, the FDA had been sued by the consumer group Public Citizen for ignoring "long-standing evidence" that fluoroquinolones can cause tendon ruptures. The consumer group had been calling upon the agency to add such a warning since 2006.

In January, Public Citizen said that from November 1997 through December 2005, the FDA had received 262 reports of tendon ruptures among fluoroquinolone users. Most involved ruptures of the Achilles' tendon. The group also cited hundreds of additional cases of tendonitis and other tendon disorders.

Fluoroquinolones are drugs approved for the treatment or prevention of certain bacterial infections. Like other antibacterial drugs, fluoroquinolones don't treat viral infections such as colds or the flu.

More information

For more on antibiotics, visit the U.S. National Library of Medicine.



SOURCE: July 8, 2008, U.S. Food and Drug Administration


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Most Companies Oppose Single-Payer Health Care System, State Coverage Mandates
2. CAHI Releases Updated Health Insurance Mandates in the States
3. New Study: Health Insurance Mandates on Employers Hurt Low-Income Employees
4. ACM Helps Medicaid Programs Comply With Federal Deficit Reduction Act Mandates
5. Aflac Named as a Top Company for Diversity by Black Enterprise Magazine
6. Religious Coalition for Reproductive Choice to Hold National Black Religious Summit on Sexuality
7. Beware the Blackberry Thumb
8. No Matter the Doctor, Black Diabetics Fare Worse Than White Counterparts
9. Morthers obesity a factor in newborn deaths for blacks, not whites, new study reports
10. Family History Plays Role in Black Colon Screen Rates
11. Black Athletes Hearts May Differ From Those of Whites

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...se action backs President Obama,s promise to not e...ample ,, Bishops still concerned for poor, el...wire/ -- Cardinal Francis George of Chicago, presi...ishops, lauded the November 7 decision of the U.S....care reform money from paying for elective abortio...
(Date:11/9/2009)...ped men and women almost equally, study finds, ,... widely used clot-dissolving drug Plavix (clopidog...nalysis of major clinical trials has found. , "... treating both men and women with this very import... cardiovascular thrombosis at New York University ...
(Date:11/9/2009)... improve letter formation could boost self-esteem,...lthDay News) -- Autistic children are more likely ...rming letters, than those without autism, research...aged 8 to 13. Half of the study participants had a...cored within the normal range for perceptual reaso...
(Date:11/9/2009)...ZHEN, China, Nov. 9 /PRNewswire-FirstCall/ - Hard ... announced today that Novartis, a US$41 billion in...% stake in HTDS, H1N1 Vaccine partner, Zhejiang Ti...llion. Novartis of Switzerland will begin a five-y...e company will dramatically increase its investmen...
(Date:11/9/2009)... New study highlights positive infl... Rosemont, IL (Vocus) Novembe...bone health decreases. Recent research has highlig...ments to help prevent these issues. However, a new... Sports Health: A Multidisciplinary Approach rev...
Breaking Medicine News(10 mins):Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 2Health News:Cardinal George Lauds House Action to Ban Federal Funds for Abortion; Promises Vigilance as Senate Pursues Health Care Reform, Wary About Affect on Poor, Elderly 3Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2
...xtend safety practices, CDC reports , , TH...ng for several years, reports of foodborne illness...ce 2004, federal health officials said Thursday. ,...all number of foodborne infections by 2010. , "Foo...
... 10, 2008) Carotid artery stenting is an effecti...ble for surgery, according to a long-term study pu...ine. Carotid artery disease, which involves cloggi...estimated 200,000 Americans each year who would ot...
...o world-leading companies have,come together to cr...A-,cleared, clinically proven light therapy techno...ate skin in the face and neck areas., (Logo: htt...ning beds, has partnered with Carlsbad, Calif.-,he...
...ers from the University of Pennsylvania School of ...signaling pathway, which determines the developmen...me cancers, is not universally essential for the m.... , Notch is one of a select set of proteins that...
... Surgery of the Head and Neck, NEW YORK, April 10...lizing in plastic and cosmetic surgery for the eth... Asian patients at a one day,Continuing Medical Ed..."Facial contouring, a commonly requested surgery a...
...nors and Mayors Support Event, ALEXANDRIA, Va., A...lthcare Decisions Day (NHDD), will be the largest,...rofessionals about,advance healthcare planning., ...e Decisions Day. "All Americans should use April 1...
Other Medicine News:Health News:Foodborne Illnesses Remain Constant in U.S. 2Health News:Foodborne Illnesses Remain Constant in U.S. 3Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 2Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 3Health News:Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology 2Health News:Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology 3Health News:Developing cancer treatments directed at critical developmental pathway 2Health News:Dr. Edmund Kwan to Speak on Facial Contouring Among Asian Patients at Cosmetic Surgery Seminar 2Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2
(Date:11/9/2009)..., NEW YORK, Nov. 9 MISSION Skin...d by tennis star Serena Williams, soccer professio... be launching "Active Lifestyle Skincare Destinati...armacy locations across the country beginning this... sun care products, MISSION and CVS/pharmacy have ...
(Date:11/9/2009)..., ROCKVILLE, Md., Nov. 9 OriGen...te of Technology in Sweden has adopted its VERIFY ...e Human Protein Atlas program. This program is fun...d is set up to explore the human proteome systemat...g high quality mono-specific antibodies in a high ...
(Date:11/9/2009)..., POTOMAC FALLS, Va., Nov. 9 Te...microarray-based applications, announces the launc...testing of the mutations that underlie human hered...ertise in microarray-based resequencing with novel...alysis software enables screening for all targeted...
Breaking Medicine Technology:Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 2Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 3Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2TessArae Delivers Lower Cost Option to Genetic Testing Market 2Hill Rom Reports Third Quarter Financial Results 53916 1Hill Rom Reports Third Quarter Financial Results 53916 2Hill Rom Reports Third Quarter Financial Results 53916 3Hill Rom Reports Third Quarter Financial Results 53916 4Hill Rom Reports Third Quarter Financial Results 53916 5Hill Rom Reports Third Quarter Financial Results 53916 6Hill Rom Reports Third Quarter Financial Results 53916 7Hill Rom Reports Third Quarter Financial Results 53916 8Hill Rom Reports Third Quarter Financial Results 53916 9Hill Rom Reports Third Quarter Financial Results 53916 10Hill Rom Reports Third Quarter Financial Results 53916 11Hill Rom Reports Third Quarter Financial Results 53916 12Hill Rom Reports Third Quarter Financial Results 53916 13Hill Rom Reports Third Quarter Financial Results 53916 14Hill Rom Reports Third Quarter Financial Results 53916 15Hill Rom Reports Third Quarter Financial Results 53916 16Hill Rom Reports Third Quarter Financial Results 53916 17Hill Rom Reports Third Quarter Financial Results 53916 18AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 1AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 2AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 3AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 4AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 5Blue Cross Blue Shield of Michigan Michigan Attorney General and Michigan Office of Financial and Insurance Regulation Near Agreement on Rate Increas 53909 1Blue Cross Blue Shield of Michigan Michigan Attorney General and Michigan Office of Financial and Insurance Regulation Near Agreement on Rate Increas 53909 2
...May 28 Robert Brackett, chief,science officer for...y,released the following statement in response to ...eported in the latest issue of the Journal of the,... the findings reported in today,s issue of the Jou...dicating that the rise in,childhood and teen obesi...
...28 ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Boa...al and,poster presentations on its Cobalamin(TM) t...r Therapeutics: Laboratory to Clinical Practice, t... presentations are entitled,"Vitamin B12-Polymer C...y,and for Oral Drug Delivery.", Cobalamin is Acce...
Other Medicine Technology:Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium 2Access Pharmaceuticals Presents New Data on the Company's Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium 3
AQuify Long-Lasting Comfort Drops
Lens Plus Rewetting Drops
Renu Rewetting Drops
Renu Multiplus Lubricating and Rewetting Drops
Medicine Products: